Omalizumab Subcutaneous and Tavist Allergy
Determining the interaction of Omalizumab Subcutaneous and Tavist Allergy and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
Generic Name: clemastine
Brand name: Tavist Allergy, Tavist, Tavist-1, Allerhist-1, Dailyhist-1, Contac 12 Hour Allergy, Dayhist Allergy
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Omalizumab Subcutaneous-Tavist ND
- Omalizumab Subcutaneous-Tavist Sinus
- Omalizumab Subcutaneous-Taxol
- Omalizumab Subcutaneous-Taxotere
- Omalizumab Subcutaneous-Taytulla
- Omalizumab Subcutaneous-Taytulla birth control
- Tavist Allergy-Ombitasvir, Paritaprevir, and Ritonavir
- Tavist Allergy-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Tavist Allergy-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Tavist Allergy-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Tavist Allergy-Omeclamox-Pak
- Tavist Allergy-Omega-3 Fatty Acid Capsules